Skip to content
Announcement:
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Blog Post:
Engineering CAR T-Cells to Function Where Others Fail
Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors
Menu
Close
Generative Biology®
The Generate Platform™
Pipeline
About Us
Careers
Media Center
Investors
LinkedIn
X
YouTube
Team Members
Gevorg Grigoryan
07.13.2026
